Contents About Semaglutide While results may vary, semaglutide has become one of the most popular weight-loss tools today
Lately, GSK-3 has been identified as an alternative target for drug-mediated neuroprotective effects against excitotoxicity of ischemic stroke in animal models because GSK-3 is a multifaceted protein with a variety of neurophysiological and cellular effects
It optimizes how fat cells store lipids, improves insulin sensitivity, and crucially blunts the severe gastrointestinal nausea typically caused by pure GLP-1 overstimulation
Additional lines of research remain more exploratory
Available from: Accessed 1 Mar 2023 Brown E, Heerspink HJL, Cuthbertson DJ, Wilding JPH (2021) SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
Semaglutide offers more safety data and an oral option